News

Scientists develop “scifi-RNA-seq” method for ultra-high-throughput RNA sequencing in single cells

AUSTROMED: Labordiagnostik muss nachhaltig im Gesundheitssystem verankert werden

DNA-based material with tunable properties

Ribbon Biolabs successfully synthesises a 10 kbp DNA molecule using their FullGenes platform

Blood test detects childhood tumors based on their epigenetic profiles

Forschungs-Update zum Welt-Multiple-Sklerose-Tag Forscher*innen widmen sich „verborgenen“ Symptomen der MS

Lexogen gains ISO 9001:2015 quality management certification

27 MAY 2021 POSITIVE PHASE 1 RESULTS WITH IMMUNOTHERAPIES TARGETING PCSK9 TO TREAT HYPERCHOLESTEROLEMIA PUBLISHED BY THE EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Marinomed Biotech AG Reports Financial Results for 1st Quarter 2021: Growth in Sales, due to persistent strong demand in Carragelose-based virus blockers

Sinovant Sciences and Nabriva Therapeutics Announce Positive Topline Results from Phase 3 Trial of Lefamulin in Chinese Adults with Community Acquired Bacterial Pneumonia (CABP)

Ribbon Biolabs successfully synthesises a 10 kbp DNA molecule using their FullGenes platform

Hilfe für PatientInnen mit Multipler Sklerose

Österreichischer Gründerpreis PHÖNIX: Die besten Start-ups, Spin-offs, Prototypen und Female Entrepreneurs werden gesucht

Pulsierende Herzen in der Petrischale

“HeartBeat.bio announces publication in Cell demonstrating the power

Valneva to Participate in the World’s First COVID-19 Vaccine Booster Trial in the UK

Zwangslizenzen und Aufhebung des Patentschutzes bringen keine rasche Verbesserung bei der Versorgung mit Impfstoffen

ÖVIH unterstützt europaweite Initiative für gerechtere Impfstoffverteilung

COVID-19: Humanes 3D-Modell enthüllt neues Angriffsziel zur Verhinderung schwerer Verläufe

Valneva Reports Q1 2021 Financial Results and Business Update